Stereotaxis, Inc. Awarded Exclusive Contract by Novation for Robotic Interventional Technology

ST. LOUIS, Sept. 10 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. announced that Novation, the leading health care supply contracting company, will add Stereotaxis’ Niobe(R) Remote Magnetic Navigation and Odyssey(TM) systems to its capital products contract portfolio. This is an exclusive agreement; Stereotaxis’ Niobe System will be the only robotic interventional technology among Novation’s capital products offerings. This agreement is effective immediately.

“Novation prides itself in developing relationships with cutting-edge companies once they have established market leadership in a particular segment,” said Michael Ainsworth, Director of Cardiovascular Contracting at Novation. “With the Niobe and Odyssey systems in our capital products portfolio, these breakthrough technologies will be more accessible to our membership. Capital equipment is among our specialties, representing up to 23 percent of our annual volume. We expect great things from our contract with Stereotaxis.”

About the Niobe(R) and Odyssey(TM) Systems

The Niobe Remote Magnetic Navigation System is installed in approximately 120 hospitals worldwide. It allows physicians to treat cardiovascular disorders with a great degree of efficiency, safety, and precision by controlling the magnetic field around the patient and directing magnetically enabled devices through the patient’s anatomy. Sophisticated software integrates medical images to create virtual reconstructions of the patient’s blood vessels and heart to help accurately guide the devices to the diseased tissue and deliver therapy while minimizing the need for x-ray exposure.

The Odyssey portfolio of products provides an innovative information backbone for managing, controlling, recording and sharing procedures performed in interventional labs. The Odyssey Workstation standardizes data integration for magnetic and standard interventional labs by enhancing the physician workflow through a consolidated display of multiple systems and eliminating the challenge of interacting simultaneously with many separate diagnostic systems. Odyssey Cinema then captures a complete record of synchronized procedure data that can be viewed live or from a comprehensive archive of cases performed. Through its proprietary data compression technology, the Odyssey enables the sharing of live and recorded procedure data via a laptop anywhere over a secure high speed Internet connection. Hospitals can also share procedures with other institutions using Odyssey Connect providing a forum for defining clinical best practices across a broad spectrum of medical procedures.

About Forward-Looking Statements

This press release includes statements that may constitute “forward-looking” statements, usually containing the words “believe,” “estimate,” “project,” “expect” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance for the Company’s products in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company’s periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that we will recognize revenue related to our purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of our control. In addition, these orders and commitments may be revised, modified or canceled, either by their express terms, as a result of negotiations, or by project changes or delays.

SOURCE Stereotaxis, Inc.

CONTACT: Company, Jim Stolze, Chief Financial Officer of Stereotaxis,
Inc., +1-314-678-6105; or Investors, Douglas Sherk or Jenifer Kirtland,
+1-415-896-6820, or Media, Steve DiMattia, +1-646-201-5445, all of EVC
Group, Inc., for Stereotaxis, Inc

Web site: http://www.stereotaxis.com/

MORE ON THIS TOPIC